Skip to main content
Clinical Trials/ISRCTN11185706
ISRCTN11185706
Suspended
未知

Problem adaptation therapy for individuals with mild to moderate dementia and depression: the PATHFINDER trial

OCLOR0 sites336 target enrollmentStarted: May 31, 2018Last updated:

Overview

Phase
未知
Status
Suspended
Sponsor
OCLOR
Enrollment
336

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1\. Diagnosis of probable AD or mixed AD and vascular dementia using NIA\-AA criteria
  • 2\. Mild to moderate dementia severity, defined by an SMMSE score \>10
  • 3\. Clinically significant depression, defined by score of 8\+ on the Cornell Scale for Depression in Dementia
  • 4\. Aged \>50 years
  • 5\. Sufficiently fluent in English to engage with the PATH intervention
  • 6\. Identified family carer who spends \>1 hour per day on at least 3 days per week with participant and agrees to act as co\-therapist for intervention

Exclusion Criteria

  • 1\. Diagnosis of rarer dementias, including dementia with Lewy bodies, Parkinson’s disease dementia and frontotemporal dementia
  • 2\. Initiation of prescription or change in dose of antidepressant or other psychotropic medication in previous 4 weeks or plan to change treatment during the next 12 weeks
  • 3\. Those currently engaged in formal psychological therapy
  • 4\. Those requiring treatment for a severe psychiatric disorder such as schizophrenia or bipolar disorder
  • 5\. Are severely depressed and expressing suicidal ideation with active plans/suicidal behaviours and intent, as other forms of treatment and support would be indicated

Investigators

Sponsor
OCLOR

Similar Trials